tiprankstipranks
CalciMedica price target lowered to $16 from $20 at H.C. Wainwright
The Fly

CalciMedica price target lowered to $16 from $20 at H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on CalciMedica (CALC) to $16 from $20 and keeps a Buy rating on the shares. The firm believes the Phase 2b CARPO data “represent a significant step forward” in the clinical advancement of Auxora. It cites dilution from the equity raise for the target cut.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App